Genmab | GEN - Interest Income


Genmab reported DKK25M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Agios Pharmaceuticals USD 12.41M 959K Dec/2025
Almirall EUR 2.71M 580K Dec/2025
Amarin USD 3.37M 3.37M Dec/2024
argenx SE USD 44.87M 2.17M Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Bayer EUR 169M 39M Dec/2025
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Exelixis USD 16.13M 1.3M Mar/2026
Fresenius Medical Care EUR 14.62M 999K Mar/2026
Genmab DKK 25M 8M Jun/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
GN Store Nord DKK -152M 221M Dec/2025
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Insmed USD 765K 55K Sep/2024
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Merck EUR 21M 6M Dec/2025
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sanofi EUR 33M 81M Dec/2025